20.99
Sionna Therapeutics Inc Aktie (SION) Neueste Nachrichten
How hedge fund analytics apply to Sionna Therapeutics Inc. stockEarnings Trend Report & Precise Trade Entry Recommendations - Newser
Why Sionna Therapeutics Inc. is moving todayEarnings Beat & Daily Market Momentum Tracking - Newser
Real time social sentiment graph for Sionna Therapeutics Inc.July 2025 PreEarnings & Stepwise Entry and Exit Trade Signals - Newser
Why Sionna Therapeutics Inc. stock attracts strong analyst attentionTrade Risk Assessment & Consistent Income Trade Recommendations - Newser
How institutional ownership impacts Sionna Therapeutics Inc. stockJuly 2025 EndofMonth & Verified Technical Signals - Newser
Quantitative breakdown of Sionna Therapeutics Inc. recent moveQuarterly Portfolio Report & Consistent Return Strategy Ideas - Newser
Has Sionna Therapeutics Inc. found a price floor2025 Investor Takeaways & Weekly High Momentum Picks - Newser
What’s next for Sionna Therapeutics Inc. stock priceQuarterly Earnings Summary & Free Weekly Watchlist of Top Performers - Newser
Short Term Trend Reversal in Sionna Therapeutics Inc. PossibleSecure Capital Picks With Upside Potential Tracked - beatles.ru
Can Sionna Therapeutics Inc. recover in the next quarterFree Watchlist for Smart Swing Trading - Newser
Sionna Therapeutics (NASDAQ:SION) Shares Gap Up After Better-Than-Expected Earnings - Defense World
Custom strategy builders for tracking Sionna Therapeutics Inc.Free Daily Picks With Predictable Performance - Newser
What makes Sionna Therapeutics Inc. stock price move sharplyReversal Pattern Insights with Entry Tips - Newser
Sionna Therapeutics shares rise 12.99% intraday after reporting positive Phase 1 data for SION-719 and SION-451. - AInvest
Guggenheim reiterates Buy rating on Sionna Therapeutics stock at $45 target - Investing.com Canada
Sionna Therapeutics' Q2 Net Loss Narrows - MarketScreener
Earnings Flash (SION) Sionna Therapeutics Posts Q2 Net Loss $0.41 a Share, vs. FactSet Est of $0.65 Loss - MarketScreener
Sionna Therapeutics Reports Second Quarter 2025 Financial Results - GlobeNewswire
Breakthrough in Cystic Fibrosis Treatment: Sionna's Novel Drugs Clear Phase 1, Phase 2 Trials Coming - Stock Titan
Custom strategy builders for tracking Cadrenal Therapeutics Inc.Long Term Stock Planner with Safety Checks - Newser
Using RSI to spot recovery in Sionna Therapeutics Inc.Buy and Exit Strategy Based on Momentum - Newser
Top chart patterns to watch in Sionna Therapeutics Inc.Weekly Breakout Forecast with Entry Zones - Newser
sionna therapeutics, inc. Earnings dates - RTTNews
Is Sionna Therapeutics Inc. trending in predictive chart modelsFree Trade Ready Stock Watch for Short Term - Newser
Guggenheim Initiates Sionna Therapeutics(SION.US) With Buy Rating, Announces Target Price $45 - 富途牛牛
Sentiment analysis tools applied to Sionna Therapeutics Inc.Buy Zone Strategy with Pattern Recognition - Newser
Published on: 2025-08-09 05:35:12 - Newser
Is AMRN stock reversal real or fakeLong Term Stock Growth Plan Suggestions - Newser
Certain Options of Sionna Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 6-AUG-2025. - MarketScreener
What momentum shifts mean for Sionna Therapeutics Inc.Entry Zone Watchlist With Momentum Focus - Newser
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):